Neurological Disorder Diagnostics Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Technology (Imaging, In Vitro Diagnostics); Disease Indication (Genetic Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic Syndrome, Paraproteinemic Neuropathies, Other Disease Indication); End User (Hospitals and Clinics, Diagnostic Centers, Ambulatory Care Centers) and Geography
MARKET INTRODUCTION Get more information on this report : Get more information on this report :
Diagnostic tests are the vital tools that help to rule out or confirm the presence of neurological disorders among individuals facing specific symptoms. The advances in brain monitoring lead to live visualization of brain interior and live brain functions. This technology helps the neurologists to diagnose neurological diseases with accuracy. The diagnosis of neurological disorders is majorly performed by using two techniques such as imaging and in vitro diagnostics.
MARKET DYNAMICS
The growth of global neurological disorder diagnostics market is expected to be driven by factors such as increasing prevalence of cerebral and neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis among others, rapid growth in the geriatric population across the globe. However, the high costs of the imaging devices are expected to hinder the growth of this market. On the other hand, the potential ability and rising adoption of biomarkers to conduct diagnosis of various diseases is one of the most prevalent trend in the neurological disorder diagnostics market.
MARKET SCOPE
The "Global Neurological Disorder Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of neurological disorder diagnostics market with detailed market segmentation by disease indication, end user and geography. The global neurological disorder diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading neurological disorder diagnostics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global neurological disorder diagnostics market is segmented on the basis of technology, disease indication, and end user. On the basis of technology, the global neurological disorder diagnostics market is segmented into imaging and in vitro diagnostics. Based on disease indication, the market is segmented into genetic neurological diseases, immunological neurological diseases, parenoplastic syndrome, paraproteinemic neuropathies, and others. On the basis of end user, the global neurological disorder diagnostics market is segmented in to hospitals & clinics, diagnostic centers, and ambulatory care centers. 
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neurological disorder diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neurological disorder diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting neurological disorder diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the neurological disorder diagnostics market in these regions.
MARKET PLAYERS
The reports cover key developments in the neurological disorder diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from neurological disorder diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for neurological disorder diagnostics market in the global market. Below mentioned is the list of few companies engaged in the neurological disorder diagnostics market.
The report also includes the profiles of key neurological disorder diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- SIEMENS
- Koninklijke Philips N.V.
- GENERAL ELECTRIC
- Esaote SpA
- NeuroLogica Corp.
- Masimo
- YORK INSTRUMENTS, INC.
- Canon Medical Systems Corporation
- Natus Medical Incorporated
- ECTRON
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study. Get more information on this report : 
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neurological Disorder Diagnostics Market - By Technology
1.3.2 Neurological Disorder Diagnostics Market - By Disease Indication
1.3.3 Neurological Disorder Diagnostics Market - By End User
1.3.4 Neurological Disorder Diagnostics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. NEUROLOGICAL DISORDER DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. NEUROLOGICAL DISORDER DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. IMAGING
7.3.1. Overview
7.3.2. Imaging Market Forecast and Analysis
7.3.3. Computed Tomography Market
7.3.3.1. Overview
7.3.3.2. Computed Tomography Market Forecast and Analysis
7.3.4. Magnetic Resonance Imaging Market
7.3.4.1. Overview
7.3.4.2. Magnetic Resonance Imaging Market Forecast and Analysis
7.3.5. Nuclear Medicine Imaging Market
7.3.5.1. Overview
7.3.5.2. Nuclear Medicine Imaging Market Forecast and Analysis
7.3.6. Positron Emission Tomography Market
7.3.6.1. Overview
7.3.6.2. Positron Emission Tomography Market Forecast and Analysis
7.3.7. Single-Photon Emission Computed Tomography (SPECT) Market
7.3.7.1. Overview
7.3.7.2. Single-Photon Emission Computed Tomography (SPECT) Market Forecast and Analysis
7.3.8. Near Infrared Spectroscopic Imaging Market
7.3.8.1. Overview
7.3.8.2. Near Infrared Spectroscopic Imaging Market Forecast and Analysis
7.3.9. Electroencephalography Market
7.3.9.1. Overview
7.3.9.2. Electroencephalography Market Forecast and Analysis
7.3.10. Magnetoencephalography Market
7.3.10.1. Overview
7.3.10.2. Magnetoencephalography Market Forecast and Analysis
7.4. IN VITRO DIAGNOSTICS
7.4.1. Overview
7.4.2. In Vitro Diagnostics Market Forecast and Analysis
7.4.3. Biomarkers Market
7.4.3.1. Overview
7.4.3.2. Biomarkers Market Forecast and Analysis
7.4.4. Biopsy Market
7.4.4.1. Overview
7.4.4.2. Biopsy Market Forecast and Analysis
7.4.5. Other In Vitro Diagnostics Market
7.4.5.1. Overview
7.4.5.2. Other In Vitro Diagnostics Market Forecast and Analysis
8. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE INDICATION
8.1. OVERVIEW
8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
8.3. GENETIC NEUROLOGICAL DISORDERS
8.3.1. Overview
8.3.2. Genetic Neurological Disorders Market Forecast and Analysis
8.4. IMMUNOLOGICAL NEUROLOGICAL DISORDERS
8.4.1. Overview
8.4.2. Immunological Neurological Disorders Market Forecast and Analysis
8.5. PARANEOPLASTIC SYNDROME
8.5.1. Overview
8.5.2. Paraneoplastic Syndrome Market Forecast and Analysis
8.6. PARAPROTEINEMIC NEUROPATHIES
8.6.1. Overview
8.6.2. Paraproteinemic Neuropathies Market Forecast and Analysis
8.7. OTHER DISEASE INDICATION
8.7.1. Overview
8.7.2. Other Disease Indication Market Forecast and Analysis
9. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND CLINICS
9.3.1. Overview
9.3.2. Hospitals and Clinics Market Forecast and Analysis
9.4. DIAGNOSTIC CENTERS
9.4.1. Overview
9.4.2. Diagnostic Centers Market Forecast and Analysis
9.5. AMBULATORY CARE CENTERS
9.5.1. Overview
9.5.2. Ambulatory Care Centers Market Forecast and Analysis
10. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Neurological Disorder Diagnostics Market Overview
10.1.2 North America Neurological Disorder Diagnostics Market Forecasts and Analysis
10.1.3 North America Neurological Disorder Diagnostics Market Forecasts and Analysis - By Technology
10.1.4 North America Neurological Disorder Diagnostics Market Forecasts and Analysis - By Disease Indication
10.1.5 North America Neurological Disorder Diagnostics Market Forecasts and Analysis - By End User
10.1.6 North America Neurological Disorder Diagnostics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Neurological Disorder Diagnostics Market
10.1.6.1.1 United States Neurological Disorder Diagnostics Market by Technology
10.1.6.1.2 United States Neurological Disorder Diagnostics Market by Disease Indication
10.1.6.1.3 United States Neurological Disorder Diagnostics Market by End User
10.1.6.2 Canada Neurological Disorder Diagnostics Market
10.1.6.2.1 Canada Neurological Disorder Diagnostics Market by Technology
10.1.6.2.2 Canada Neurological Disorder Diagnostics Market by Disease Indication
10.1.6.2.3 Canada Neurological Disorder Diagnostics Market by End User
10.1.6.3 Mexico Neurological Disorder Diagnostics Market
10.1.6.3.1 Mexico Neurological Disorder Diagnostics Market by Technology
10.1.6.3.2 Mexico Neurological Disorder Diagnostics Market by Disease Indication
10.1.6.3.3 Mexico Neurological Disorder Diagnostics Market by End User
10.2. EUROPE
10.2.1 Europe Neurological Disorder Diagnostics Market Overview
10.2.2 Europe Neurological Disorder Diagnostics Market Forecasts and Analysis
10.2.3 Europe Neurological Disorder Diagnostics Market Forecasts and Analysis - By Technology
10.2.4 Europe Neurological Disorder Diagnostics Market Forecasts and Analysis - By Disease Indication
10.2.5 Europe Neurological Disorder Diagnostics Market Forecasts and Analysis - By End User
10.2.6 Europe Neurological Disorder Diagnostics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Neurological Disorder Diagnostics Market
10.2.6.1.1 Germany Neurological Disorder Diagnostics Market by Technology
10.2.6.1.2 Germany Neurological Disorder Diagnostics Market by Disease Indication
10.2.6.1.3 Germany Neurological Disorder Diagnostics Market by End User
10.2.6.2 France Neurological Disorder Diagnostics Market
10.2.6.2.1 France Neurological Disorder Diagnostics Market by Technology
10.2.6.2.2 France Neurological Disorder Diagnostics Market by Disease Indication
10.2.6.2.3 France Neurological Disorder Diagnostics Market by End User
10.2.6.3 Italy Neurological Disorder Diagnostics Market
10.2.6.3.1 Italy Neurological Disorder Diagnostics Market by Technology
10.2.6.3.2 Italy Neurological Disorder Diagnostics Market by Disease Indication
10.2.6.3.3 Italy Neurological Disorder Diagnostics Market by End User
10.2.6.4 Spain Neurological Disorder Diagnostics Market
10.2.6.4.1 Spain Neurological Disorder Diagnostics Market by Technology
10.2.6.4.2 Spain Neurological Disorder Diagnostics Market by Disease Indication
10.2.6.4.3 Spain Neurological Disorder Diagnostics Market by End User
10.2.6.5 United Kingdom Neurological Disorder Diagnostics Market
10.2.6.5.1 United Kingdom Neurological Disorder Diagnostics Market by Technology
10.2.6.5.2 United Kingdom Neurological Disorder Diagnostics Market by Disease Indication
10.2.6.5.3 United Kingdom Neurological Disorder Diagnostics Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Neurological Disorder Diagnostics Market Overview
10.3.2 Asia-Pacific Neurological Disorder Diagnostics Market Forecasts and Analysis
10.3.3 Asia-Pacific Neurological Disorder Diagnostics Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Neurological Disorder Diagnostics Market Forecasts and Analysis - By Disease Indication
10.3.5 Asia-Pacific Neurological Disorder Diagnostics Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Neurological Disorder Diagnostics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Neurological Disorder Diagnostics Market
10.3.6.1.1 Australia Neurological Disorder Diagnostics Market by Technology
10.3.6.1.2 Australia Neurological Disorder Diagnostics Market by Disease Indication
10.3.6.1.3 Australia Neurological Disorder Diagnostics Market by End User
10.3.6.2 China Neurological Disorder Diagnostics Market
10.3.6.2.1 China Neurological Disorder Diagnostics Market by Technology
10.3.6.2.2 China Neurological Disorder Diagnostics Market by Disease Indication
10.3.6.2.3 China Neurological Disorder Diagnostics Market by End User
10.3.6.3 India Neurological Disorder Diagnostics Market
10.3.6.3.1 India Neurological Disorder Diagnostics Market by Technology
10.3.6.3.2 India Neurological Disorder Diagnostics Market by Disease Indication
10.3.6.3.3 India Neurological Disorder Diagnostics Market by End User
10.3.6.4 Japan Neurological Disorder Diagnostics Market
10.3.6.4.1 Japan Neurological Disorder Diagnostics Market by Technology
10.3.6.4.2 Japan Neurological Disorder Diagnostics Market by Disease Indication
10.3.6.4.3 Japan Neurological Disorder Diagnostics Market by End User
10.3.6.5 South Korea Neurological Disorder Diagnostics Market
10.3.6.5.1 South Korea Neurological Disorder Diagnostics Market by Technology
10.3.6.5.2 South Korea Neurological Disorder Diagnostics Market by Disease Indication
10.3.6.5.3 South Korea Neurological Disorder Diagnostics Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Neurological Disorder Diagnostics Market Overview
10.4.2 Middle East and Africa Neurological Disorder Diagnostics Market Forecasts and Analysis
10.4.3 Middle East and Africa Neurological Disorder Diagnostics Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Neurological Disorder Diagnostics Market Forecasts and Analysis - By Disease Indication
10.4.5 Middle East and Africa Neurological Disorder Diagnostics Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Neurological Disorder Diagnostics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Neurological Disorder Diagnostics Market
10.4.6.1.1 South Africa Neurological Disorder Diagnostics Market by Technology
10.4.6.1.2 South Africa Neurological Disorder Diagnostics Market by Disease Indication
10.4.6.1.3 South Africa Neurological Disorder Diagnostics Market by End User
10.4.6.2 Saudi Arabia Neurological Disorder Diagnostics Market
10.4.6.2.1 Saudi Arabia Neurological Disorder Diagnostics Market by Technology
10.4.6.2.2 Saudi Arabia Neurological Disorder Diagnostics Market by Disease Indication
10.4.6.2.3 Saudi Arabia Neurological Disorder Diagnostics Market by End User
10.4.6.3 U.A.E Neurological Disorder Diagnostics Market
10.4.6.3.1 U.A.E Neurological Disorder Diagnostics Market by Technology
10.4.6.3.2 U.A.E Neurological Disorder Diagnostics Market by Disease Indication
10.4.6.3.3 U.A.E Neurological Disorder Diagnostics Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Neurological Disorder Diagnostics Market Overview
10.5.2 South and Central America Neurological Disorder Diagnostics Market Forecasts and Analysis
10.5.3 South and Central America Neurological Disorder Diagnostics Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Neurological Disorder Diagnostics Market Forecasts and Analysis - By Disease Indication
10.5.5 South and Central America Neurological Disorder Diagnostics Market Forecasts and Analysis - By End User
10.5.6 South and Central America Neurological Disorder Diagnostics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Neurological Disorder Diagnostics Market
10.5.6.1.1 Brazil Neurological Disorder Diagnostics Market by Technology
10.5.6.1.2 Brazil Neurological Disorder Diagnostics Market by Disease Indication
10.5.6.1.3 Brazil Neurological Disorder Diagnostics Market by End User
10.5.6.2 Argentina Neurological Disorder Diagnostics Market
10.5.6.2.1 Argentina Neurological Disorder Diagnostics Market by Technology
10.5.6.2.2 Argentina Neurological Disorder Diagnostics Market by Disease Indication
10.5.6.2.3 Argentina Neurological Disorder Diagnostics Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. SIEMENS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. KONINKLIJKE PHILIPS N.V.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GENERAL ELECTRIC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ESAOTE SPA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NEUROLOGICA CORP.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MASIMO
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. YORK INSTRUMENTS, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CANON MEDICAL SYSTEMS CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NATUS MEDICAL INCORPORATED
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ECTRON
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. SIEMENS
2. Koninklijke Philips N.V.
3. GENERAL ELECTRIC
4. Esaote SpA
5. NeuroLogica Corp.
6. Masimo
7. YORK INSTRUMENTS, INC.
8. Canon Medical Systems Corporation
9. Natus Medical Incorporated
10. ECTRON